Abstract
Objective: Endocrine therapy is widely used - often for many years - in women with breast cancer. Yet little is known about cognitive functioning after long-term use of tamoxifen. We examine cognitive sequelae, approximately 3 years after diagnosis, in postmenopausal women with breast cancer who were treated with adjuvant tamoxifen.
Original language | English |
---|---|
Pages (from-to) | 17-25 |
Journal | Menopause |
Volume | 22 |
Issue number | 1 |
Early online date | 25 Jun 2014 |
DOIs | |
Publication status | Published - 2015 |